{"transactions":[{"id":692987,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-08-07T21:37:52.000Z","date":"2026-08-07","kind":"grant","planned":false,"acquired":true,"shares":1090000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that will vest on August 31, 2027 subject to (a) the Reporting Person's continued employment through such date or (b) the termination of the Reporting Person's employment by the Company for any reason other than For Cause, By Death or By Disability (each, as defined in the Reporting Person's Executive Employment Agreement), provided the Reporting Person executes and does not revoke the release agreement appended to the Reporting Person's Executive Employment Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":1419823,"source":{"system":"sec-edgar","filing":"0001628280-26-054941","document":"wk-form4_1786138670.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026054941/wk-form4_1786138670.xml","form_type":"4"}},{"id":819347,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":21586,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests in equal monthly installments over the four year period beginning August 24, 2023. The grant date for the stock option is August 25, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.5,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":21586},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819346,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":21586,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests in equal monthly installments over the four year period beginning August 24, 2023. The grant date for the stock option is August 25, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":21586,"derivative":{"exercise_price":0.615,"expiration_date":"2033-09-29","underlying":"Common Stock","underlying_shares":21586},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819345,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":9013,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests in equal monthly installments over the four year period beginning August\n24, 2023. The grant date for the stock option is November 6, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested"}],"balance_after":0,"derivative":{"exercise_price":3.5,"expiration_date":"2033-11-06","underlying":"Common Stock","underlying_shares":9013},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819344,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":9013,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The stock option vests in equal monthly installments over the four year period beginning August\n24, 2023. The grant date for the stock option is November 6, 2023. Upon a change in control of the Issuer, 100% of the stock option will become fully vested"}],"balance_after":9013,"derivative":{"exercise_price":0.615,"expiration_date":"2033-11-06","underlying":"Common Stock","underlying_shares":9013},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819343,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in equal monthly installments over the four year period beginning February 29, 2024.  The grant date for the stock option is March 1, 2024. Upon a change in control of the Issuer, 100% of the stock options will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819342,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option vests in equal monthly installments over the four year period beginning February 29, 2024.  The grant date for the stock option is March 1, 2024. Upon a change in control of the Issuer, 100% of the stock options will become fully vested."}],"balance_after":125000,"derivative":{"exercise_price":0.615,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819341,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":650000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in equal monthly installments over the four year period beginning October 28, 2024. The grant date for the stock option is October 27, 2024. Upon a change of control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.15,"expiration_date":"2034-10-27","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819340,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":650000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests in equal monthly installments over the four year period beginning October 28, 2024. The grant date for the stock option is October 27, 2024. Upon a change of control of the Issuer, 100% of the stock option will become fully vested."}],"balance_after":650000,"derivative":{"exercise_price":0.615,"expiration_date":"2034-10-27","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819339,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":12360,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":14.5,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":12360},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819338,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":12360,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":12360,"derivative":{"exercise_price":0.615,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":12360},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819337,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.25,"expiration_date":"2030-08-07","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819336,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":36000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":36000,"derivative":{"exercise_price":0.615,"expiration_date":"2030-08-07","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819335,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.89,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":819334,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-02T22:06:22.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock option is $0.615 per share, representing the closing price of the Issuer's common stock on the date of the repricing."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On March 31, 2026, the board of directors of the Issuer approved the one-time repricing of the stock option effective as of March 31, 2026. Except as described in footnote 1, all other terms of the stock option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is fully vested."}],"balance_after":250000,"derivative":{"exercise_price":0.615,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001628280-26-023337","document":"wk-form4_1775167579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026023337/wk-form4_1775167579.xml","form_type":"4"}},{"id":914298,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T01:54:11.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the four-year period beginning January 19, 2026."}],"balance_after":280000,"derivative":{"exercise_price":0.82,"expiration_date":"2036-02-06","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001628280-26-006618","document":"wk-form4_1770688448.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000162828026006618/wk-form4_1770688448.xml","form_type":"4"}},{"id":1242773,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-26T22:43:44.000Z","date":"2025-02-24","kind":"grant","planned":false,"acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the one year period beginning February 21, 2025."}],"balance_after":250000,"derivative":{"exercise_price":2.89,"expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001516551-25-000010","document":"wk-form4_1740609817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655125000010/wk-form4_1740609817.xml","form_type":"4"}},{"id":1358842,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-20T02:20:46.000Z","date":"2024-11-18","kind":"sale","planned":false,"acquired":false,"shares":82546,"price":4.99,"value":411904.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold as part of a block trade in multiple transactions at prices ranging from $4.98 to $5.08, inclusive. The Reporting Person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price with regard to the block trade."}],"balance_after":329823,"source":{"system":"sec-edgar","filing":"0001516551-24-000116","document":"wk-form4_1732069239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000116/wk-form4_1732069239.xml","form_type":"4"}},{"id":1358841,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-20T02:20:46.000Z","date":"2024-11-15","kind":"sale","planned":false,"acquired":false,"shares":364,"price":5.55,"value":2020.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of performance-based restricted stock units. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and do not represent discretionary transactions by the Reporting Person."}],"balance_after":412369,"source":{"system":"sec-edgar","filing":"0001516551-24-000116","document":"wk-form4_1732069239.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000116/wk-form4_1732069239.xml","form_type":"4"}},{"id":1379333,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-31T00:31:23.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments over the four year period beginning October 28, 2024."}],"balance_after":650000,"derivative":{"exercise_price":5.15,"expiration_date":"2034-10-27","underlying":"Common Stock","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001516551-24-000101","document":"wk-form4_1730334676.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000101/wk-form4_1730334676.xml","form_type":"4"}},{"id":1421837,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-27T21:20:42.000Z","date":"2024-08-26","kind":"other","planned":false,"acquired":true,"shares":15727,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received by reporting person in connection with one of Issuer's shareholders pro rata distribution of common stock of Issuer to its shareholders."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received by reporting person in connection with one of Issuer's shareholders pro rata distribution of common stock of Issuer to its shareholders."}],"balance_after":412733,"source":{"system":"sec-edgar","filing":"0001516551-24-000078","document":"wk-form4_1724793636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000078/wk-form4_1724793636.xml","form_type":"4"}},{"id":1602829,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T11:13:46.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the four year period beginning February 29, 2024.  Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":125000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001516551-24-000014","document":"wk-form4a_1709550818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000014/wk-form4a_1709550818.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1602828,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-04T11:13:46.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the following milestones: 25% vests upon achieving a market cap of $750M and a stock price of $20.00 per share, an additional 25% vests upon achieving a market cap of $1B and a stock price of $25.00 per share, an additional 25% vests upon achieving a market cap of $1.25B and a stock price of $30.00 per share, an additional 25% vest upon achieving a market cap of $1.5B or greater and a stock price of $35.00 per share; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs. Upon a change in control of the Issuer, 100% of the RSUs will become fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":397006,"source":{"system":"sec-edgar","filing":"0001516551-24-000014","document":"wk-form4a_1709550818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000014/wk-form4a_1709550818.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1606808,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-01T23:24:43.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant shall be exercisable for a price of $14.56 per option share for ten years from February 29, 2024 and the options will vest in equal monthly installments over the four year period beginning February 29, 2024.  Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":125000,"derivative":{"exercise_price":14.56,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001516551-24-000010","document":"wk-form4_1709335471.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000010/wk-form4_1709335471.xml","form_type":"4"}},{"id":1606807,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-01T23:24:43.000Z","date":"2024-02-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $750M and a stock price of $20.00 per share, an additional 25% vests upon achieving a market cap of $1B and a stock price of $25.00 per share, an additional 25% vests upon achieving a market cap of $1.25B and a stock price of $30.00 per share, an additional 25% vest at if the Company is acquired for total consideration of $1.5B or greater and a stock price of $35.00 per share; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs. Upon a change in control of the Issuer, 100% of the options will become fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":397006,"source":{"system":"sec-edgar","filing":"0001516551-24-000010","document":"wk-form4_1709335471.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655124000010/wk-form4_1709335471.xml","form_type":"4"}},{"id":1748521,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-07T01:29:48.000Z","date":"2023-11-06","kind":"grant","planned":false,"acquired":true,"shares":21586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant shall be exercisable for a price of $3.50 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the four year period beginning August 24, 2023. Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":30599,"derivative":{"exercise_price":3.5,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":21586},"source":{"system":"sec-edgar","filing":"0001516551-23-000095","document":"wk-form4_1699320579.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000095/wk-form4_1699320579.xml","form_type":"4"}},{"id":1748520,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-11-07T01:29:48.000Z","date":"2023-11-06","kind":"grant","planned":false,"acquired":true,"shares":194270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $125M, an additional 25% vests upon achieving a market cap of $250M, an additional 25% vests upon achieving a market cap of $400M, an additional 25% vest at an exit of $500M or greater; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs. Notwithstanding anything to the foregoing, all of the RSUS shall vest if an exit greater than $500M is achieved at an earlier date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":297006,"source":{"system":"sec-edgar","filing":"0001516551-23-000095","document":"wk-form4_1699320579.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000095/wk-form4_1699320579.xml","form_type":"4"}},{"id":1791898,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-31T15:26:52.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":2253046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant shall be exercisable for a price of $0.014 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the four year period beginning August 24, 2023. Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":2253046,"derivative":{"exercise_price":0.014,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":2253046},"source":{"system":"sec-edgar","filing":"0001516551-23-000069","document":"wk-form4a_1693495603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000069/wk-form4a_1693495603.xml","form_type":"4/A","original_submission_date":"2023-08-29"}},{"id":1791897,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-31T15:26:52.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":881000,"price":0.0187,"value":16474.7,"ownership":{"direct":true},"balance_after":25683957,"source":{"system":"sec-edgar","filing":"0001516551-23-000069","document":"wk-form4a_1693495603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000069/wk-form4a_1693495603.xml","form_type":"4/A","original_submission_date":"2023-08-29"}},{"id":1791896,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-31T15:26:52.000Z","date":"2023-08-28","kind":"other","planned":false,"acquired":true,"shares":110000,"price":0.0171,"value":1881.0,"ownership":{"direct":true},"balance_after":24802957,"source":{"system":"sec-edgar","filing":"0001516551-23-000069","document":"wk-form4a_1693495603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000069/wk-form4a_1693495603.xml","form_type":"4/A","original_submission_date":"2023-08-29"}},{"id":1791895,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-31T15:26:52.000Z","date":"2023-08-23","kind":"other","planned":false,"acquired":true,"shares":9000,"price":0.0118,"value":106.2,"ownership":{"direct":true},"balance_after":24692957,"source":{"system":"sec-edgar","filing":"0001516551-23-000069","document":"wk-form4a_1693495603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000069/wk-form4a_1693495603.xml","form_type":"4/A","original_submission_date":"2023-08-29"}},{"id":1791894,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-31T15:26:52.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":20277414,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $125M, an additional 25% vests upon achieving a market cap of $250M, an additional 25% vests upon achieving a market cap of $400M, an additional 25% vest at an exit of $500M or greater; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs . Notwithstanding anything to the foregoing, all of the RSUS shall vest if an exit greater than $500M is achieved at an earlier date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":24683957,"source":{"system":"sec-edgar","filing":"0001516551-23-000069","document":"wk-form4a_1693495603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000069/wk-form4a_1693495603.xml","form_type":"4/A","original_submission_date":"2023-08-29"}},{"id":1794148,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-29T22:39:44.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":2253046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option grant shall be exercisable for a price of $0.014 per option share for ten years from August 25, 2023 and the options will vest in equal monthly installments over the four year period beginning August 24, 2023. Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":2253046,"derivative":{"exercise_price":0.014,"expiration_date":"2033-08-25","underlying":"Common Stock","underlying_shares":2253046},"source":{"system":"sec-edgar","filing":"0001516551-23-000062","document":"wk-form4_1693348773.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000062/wk-form4_1693348773.xml","form_type":"4"}},{"id":1794147,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-29T22:39:44.000Z","date":"2023-08-29","kind":"purchase","planned":false,"acquired":true,"shares":881000,"price":0.0187,"value":16474.7,"ownership":{"direct":true},"balance_after":41554828,"source":{"system":"sec-edgar","filing":"0001516551-23-000062","document":"wk-form4_1693348773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000062/wk-form4_1693348773.xml","form_type":"4"}},{"id":1794146,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-29T22:39:44.000Z","date":"2023-08-28","kind":"other","planned":false,"acquired":true,"shares":110000,"price":0.0171,"value":1881.0,"ownership":{"direct":true},"balance_after":40673828,"source":{"system":"sec-edgar","filing":"0001516551-23-000062","document":"wk-form4_1693348773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000062/wk-form4_1693348773.xml","form_type":"4"}},{"id":1794145,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-29T22:39:44.000Z","date":"2023-08-23","kind":"other","planned":false,"acquired":true,"shares":9000,"price":0.0118,"value":106.2,"ownership":{"direct":true},"balance_after":40563828,"source":{"system":"sec-edgar","filing":"0001516551-23-000062","document":"wk-form4_1693348773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000062/wk-form4_1693348773.xml","form_type":"4"}},{"id":1794144,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-29T22:39:44.000Z","date":"2023-08-25","kind":"grant","planned":false,"acquired":true,"shares":20277414,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests on the following performance milestones : 25% vests upon achieving a market cap of $125M, an additional 25% vests upon achieving a market cap of $250M, an additional 25% vests upon achieving a market cap of $400M, an additional 25% vest at an exit of $500M or greater; provided, however, that no RSUs shall vest until the compensation committee of the Issuer determines that shares can be sold into the market to cover withholding tax obligations associated with the vesting of the RSUs . Notwithstanding anything to the foregoing, all of the RSUS shall vest if an exit greater than $500M is achieved at an earlier date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":40554828,"source":{"system":"sec-edgar","filing":"0001516551-23-000062","document":"wk-form4_1693348773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655123000062/wk-form4_1693348773.xml","form_type":"4"}},{"id":2115993,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T18:41:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":292500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"8.33% of the options vested on the grant date of August 3, 2020. An additional 8.333% of the options vest on each monthly anniversary of the grant date."}],"balance_after":292500,"derivative":{"exercise_price":0.08,"expiration_date":"2025-08-03","underlying":"Common Stock","underlying_shares":292500},"source":{"system":"sec-edgar","filing":"0001516551-22-000047","document":"wf-form4_166853764730845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655122000047/wf-form4_166853764730845.xml","form_type":"4"}},{"id":2115992,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T18:41:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":487500,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options underlying this award are fully vested."}],"balance_after":487500,"derivative":{"exercise_price":0.06,"expiration_date":"2025-04-27","underlying":"Common Stock","underlying_shares":487500},"source":{"system":"sec-edgar","filing":"0001516551-22-000047","document":"wf-form4_166853764730845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655122000047/wf-form4_166853764730845.xml","form_type":"4"}},{"id":2115991,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T18:41:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":390000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options will vest, or have vested, in equal installments on each of February 6, 2020, February 6, 2021, February 6, 2022, February 6, 2023."}],"balance_after":390000,"derivative":{"exercise_price":0.11,"expiration_date":"2025-02-06","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001516551-22-000047","document":"wf-form4_166853764730845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655122000047/wf-form4_166853764730845.xml","form_type":"4"}},{"id":2115990,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-15T18:41:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":390000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement. Pursuant to the terms of the Arrangement Agreement, each option to purchase EHT shares was exchanged into an option to purchase shares of company common stock, with the number of shares underlying each option (and the exercise price of such option) adjusted based on the Exchange Ratio."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The options underlying this award are fully vested."}],"balance_after":390000,"derivative":{"exercise_price":1.6,"expiration_date":"2024-04-03","underlying":"Common Stock","underlying_shares":390000},"source":{"system":"sec-edgar","filing":"0001516551-22-000047","document":"wf-form4_166853764730845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655122000047/wf-form4_166853764730845.xml","form_type":"4"}},{"id":2115989,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-15T18:41:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":2335721,"ownership":{"direct":false,"nature":"Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by a trust for which the Reporting Person is a trustee and has voting and dispositive power over the shares."}],"balance_after":2335721,"source":{"system":"sec-edgar","filing":"0001516551-22-000047","document":"wf-form4_166853764730845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655122000047/wf-form4_166853764730845.xml","form_type":"4"}},{"id":2115988,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-15T18:41:05.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":1406543,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reporting person acquired these securities on November 10th, 2022, in exchange for the reporting person's securities of Emerald Health Therapeutics, Inc., which the company acquired by way of a plan of arrangement pursuant to the Arrangement Agreement, dated as of May 11, 2022 (as amended, the \"Arrangement Agreement\"). Pursuant to the terms of the Arrangement Agreement, each holder of EHT shares received 1.95 shares of company common stock for each EHT share (the \"Exchange Ratio\")."}],"balance_after":4406543,"source":{"system":"sec-edgar","filing":"0001516551-22-000047","document":"wf-form4_166853764730845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655122000047/wf-form4_166853764730845.xml","form_type":"4"}},{"id":2119881,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-11-11T02:54:22.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the \"Plan\"). The option shall vest equally on each of the first 12 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable."}],"balance_after":250000,"derivative":{"exercise_price":0.0401,"expiration_date":"2032-11-10","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001415889-22-011314","document":"form4-11112022_021112.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000141588922011314/form4-11112022_021112.xml","form_type":"4"}},{"id":2469719,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-17T00:03:12.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":3090000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests 25% on the one year anniversary of the grant date and 1/48th monthly thereafter. Upon a change in control of the Issuer, 100% of the options will become fully vested."}],"balance_after":3090000,"derivative":{"exercise_price":0.058,"expiration_date":"2031-12-14","underlying":"Common Stock","underlying_shares":3090000},"source":{"system":"sec-edgar","filing":"0001516551-21-000029","document":"wf-form4_163969937662511.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655121000029/wf-form4_163969937662511.xml","form_type":"4"}},{"id":2469718,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-12-17T00:03:12.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":2000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award that vests in three equal annual installments commencing on the first anniversary of the grant date. Upon a change in control of the Issuer, all of the RSUs will vest in full."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":3000000,"source":{"system":"sec-edgar","filing":"0001516551-21-000029","document":"wf-form4_163969937662511.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000151655121000029/wf-form4_163969937662511.xml","form_type":"4"}},{"id":2554251,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-01T12:11:08.000Z","date":"2021-09-27","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted pursuant to the Plan. 1/3 of the option vested on the grant date and the remainder of the option shall vest equally on each of the first 24 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable."}],"balance_after":250000,"derivative":{"exercise_price":0.1028,"expiration_date":"2031-09-26","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-121632","document":"tm2129012d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000110465921121632/tm2129012d2_4.xml","form_type":"4"}},{"id":2554250,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-10-01T12:11:08.000Z","date":"2021-09-27","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted pursuant to the Issuer's 2013 Stock Incentive Plan (the \"Plan\"). The option shall vest equally on each of the first 36 month anniversaries of the grant date, subject to continued service to the Issuer through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), 100% of the number of unvested shares then subject to the option shall accelerate and become immediately exercisable."}],"balance_after":250000,"derivative":{"exercise_price":0.1028,"expiration_date":"2031-09-26","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001104659-21-121632","document":"tm2129012d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000110465921121632/tm2129012d2_4.xml","form_type":"4"}},{"id":3061797,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Employee Option Grant (Right to Buy)","published_at":"2020-08-11T18:53:08.000Z","date":"2020-08-07","kind":"grant","acquired":true,"shares":9000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the \"Grant Date\") and all\nOptions will vest 10% on the Grant Date and 90% in equal semiannual installments over four and a half years."}],"balance_after":9200000,"derivative":{"exercise_price":0.045,"expiration_date":"2030-08-07","underlying":"Common Stock","underlying_shares":9000000},"source":{"system":"sec-edgar","filing":"0001640334-20-002027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000164033420002027/form4.xml","form_type":"4"}},{"id":3061796,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2020-08-11T18:53:08.000Z","date":"2020-08-07","kind":"purchase","acquired":true,"shares":1000000,"price":100000,"value":100000000000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Private purchase transaction from Emerald Health Sciences at $0.10 per share."}],"balance_after":1000000,"source":{"system":"sec-edgar","filing":"0001640334-20-002027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000164033420002027/form4.xml","form_type":"4"}},{"id":3332391,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-23T13:32:59.000Z","date":"2019-12-20","kind":"grant","acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Of the Shares subject to the Option, 1/12 shall vest on each of the next twelve (12) monthly anniversaries of the Vesting Commencement Date. In the event of a Change of Control (as such term is defined in the Plan) all Options subject to this grant will immediately vest."}],"balance_after":300000,"derivative":{"exercise_price":0.2292,"expiration_date":"2029-12-19","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001104659-19-075320","document":"tm1926824-2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000110465919075320/tm1926824-2_4.xml","form_type":"4"}},{"id":3703867,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-04T21:01:57.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This is a long-term equity incentive award of stock options which will vest quarterly over the next three years. The first vesting will occur on 1/31/2019, and the award will be fully vested on 10/31/2021 pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":50000,"derivative":{"exercise_price":0.655,"exercise_date":"2019-01-31","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001493152-19-000205","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315219000205/ownership.xml","form_type":"4"}},{"id":3791894,"issuer":{"id":8098,"kind":"organization","name":"Skye Bioscience, Inc.","symbol":"SKYE"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-10-12T16:17:20.000Z","date":"2018-10-10","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in equal monthly installments over a one-year period commencing on the date of grant."}],"balance_after":200000,"derivative":{"exercise_price":0.305,"expiration_date":"2028-10-10","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-054866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000120919118054866/doc4.xml","form_type":"4"}},{"id":3863616,"issuer":{"id":109849,"kind":"organization","name":"Arch Therapeutics, Inc.","symbol":"ARTH"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-20T16:03:43.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Of the Shares subject to this Grant, 1/12th shall on each of the next twelve (12) monthly anniversaries of the vesting commencement date."}],"balance_after":200000,"derivative":{"exercise_price":0.425,"expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001144204-18-039093","document":"tv498877_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1425052/000114420418039093/tv498877_4.xml","form_type":"4"}},{"id":3871114,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2018-11-04","expiration_date":"2018-11-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871113,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2020-03-29","expiration_date":"2020-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871112,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2019-03-04","expiration_date":"2019-03-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871111,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":32000,"price":1.312,"value":41984.0,"ownership":{"direct":true},"balance_after":485262,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871110,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":13785,"price":1.312,"value":18085.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":517262,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871109,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-29","kind":"sale","acquired":false,"shares":5401,"price":1.38,"value":7453.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":531047,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871108,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-28","kind":"sale","acquired":false,"shares":7882,"price":1.401,"value":11042.682,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":536448,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871107,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":17480,"price":1.374,"value":24017.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":544330,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871106,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-26","kind":"sale","acquired":false,"shares":23820,"price":1.398,"value":33300.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":561810,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871105,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-25","kind":"sale","acquired":false,"shares":1021,"price":1.405,"value":1434.505,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":585630,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871104,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-22","kind":"sale","acquired":false,"shares":14976,"price":1.418,"value":21235.968,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":586651,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871103,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":11035,"price":1.401,"value":15460.035,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":601627,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871102,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":55585,"price":1.422,"value":79041.87,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":612662,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871101,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":9310,"price":1.364,"value":12698.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":668247,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871100,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":28145,"price":1.386,"value":39008.97,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":677557,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871099,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":705702,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871098,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":505702,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871097,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-09T21:11:46.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":355702,"source":{"system":"sec-edgar","filing":"0001493152-18-009835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009835/ownership.xml","form_type":"4/A","original_submission_date":"2018-07-06"}},{"id":3871751,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2018-11-04","expiration_date":"2018-11-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871750,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2020-03-29","expiration_date":"2020-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871749,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-15","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":0,"derivative":{"exercise_date":"2019-03-04","expiration_date":"2019-03-04","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871748,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-07-05","kind":"sale","acquired":false,"shares":45785,"price":1.312,"value":60069.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":485262,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871747,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-29","kind":"sale","acquired":false,"shares":5401,"price":1.38,"value":7453.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":531047,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871746,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-28","kind":"sale","acquired":false,"shares":7882,"price":1.401,"value":11042.682,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":536448,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871745,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-27","kind":"sale","acquired":false,"shares":17480,"price":1.374,"value":24017.52,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":544330,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871744,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-26","kind":"sale","acquired":false,"shares":23820,"price":1.398,"value":33300.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":561810,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871743,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-25","kind":"sale","acquired":false,"shares":1021,"price":1.405,"value":1434.505,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":585630,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871742,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-22","kind":"sale","acquired":false,"shares":14976,"price":1.418,"value":21235.968,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":586651,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871741,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-21","kind":"sale","acquired":false,"shares":11035,"price":1.401,"value":15460.035,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":601627,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871740,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-20","kind":"sale","acquired":false,"shares":55585,"price":1.422,"value":79041.87,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":612662,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871739,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-19","kind":"sale","acquired":false,"shares":9310,"price":1.364,"value":12698.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":668247,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871738,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-18","kind":"sale","acquired":false,"shares":28145,"price":1.386,"value":39008.97,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Sale to cover taxes on restricted stock unit vesting."}],"balance_after":677557,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871737,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":705702,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871736,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":505702,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871735,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-06T16:40:37.000Z","date":"2018-06-15","kind":"exercise","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."}],"balance_after":355702,"source":{"system":"sec-edgar","filing":"0001493152-18-009769","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009769/ownership.xml","form_type":"4"}},{"id":3871721,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2018-07-06T16:05:24.000Z","date":"2018-02-06","kind":"grant","acquired":true,"shares":3000,"price":0.88,"value":2640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This amended Form 4 is being filed to correctly reflect the Reporting Person's exempt acquisition of shares pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan. The Reporting Person acquired the shares pursuant to the plan on February 1, 2018, and subsequently transferred the shares to a living trust. The original Form 4 filed on February 6 used an incorrect transaction code that indicated they were acquired through an open market purchase."}],"balance_after":230702,"source":{"system":"sec-edgar","filing":"0001493152-18-009761","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218009761/ownership.xml","form_type":"4/A","original_submission_date":"2018-02-06"}},{"id":4068477,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Restricted Stock Units","published_at":"2018-02-09T17:43:32.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Amended and Restated Executive Employment Agreement, dated November 7, 2017, between OncoSec Medical Incorporated\nand Punit Dhillon, the restricted stock units vest in 12 equal monthly increments, with the first 1/12th vesting on the first monthly anniversary of the Grant Date pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan; however, pursuant to a subsequent lock-up agreement related to OncoSec's financing, dated February 1, 2018, vesting is deferred until May 7, 2018."}],"balance_after":475583,"derivative":{"exercise_date":"2018-03-08","expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001493152-18-001772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218001772/form4.xml","form_type":"4"}},{"id":4068476,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Option to Purchase Common Stock","published_at":"2018-02-09T17:43:32.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":300000,"price":1.64,"value":492000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested on the Grant Date, and the remaining 75% to vest in 36 equal monthly increments, beginning on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":1114583,"derivative":{"exercise_price":1.64,"exercise_date":"2018-03-08","expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001493152-18-001772","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218001772/form4.xml","form_type":"4"}},{"id":4073689,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Common Stock","published_at":"2018-02-06T14:57:53.000Z","date":"2018-02-06","kind":"purchase","acquired":true,"shares":3000,"price":0.88,"value":2640.0,"ownership":{"direct":false,"nature":"By the Dhillon Living Trust dated May 24, 2017"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares purchased were pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Dhillon Living Trust dated May 24, 2017"}],"balance_after":230702,"source":{"system":"sec-edgar","filing":"0001493152-18-001525","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218001525/form4.xml","form_type":"4"}},{"id":4097774,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-17T16:30:14.000Z","date":"2018-01-12","kind":"grant","acquired":true,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"OncoSec's (ONCS) stock closing price was $1.32 on November 4, 2017."},{"field":"date","element":"transactionDate","label":"F2","text":"The Stock Options to purchase 250,000 shares of common stock of the issuer were approved by OncoSec's Board of Directors on November 4, 2017 (\"Grant Date\") and the contingency restriction was removed after OncoSec's Annual Stockholders Meeting held on January 12, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options to purchase 250,000 shares of common stock of the issuer were approved by OncoSec's Board of Directors on November 4, 2017 (\"Grant Date\") and the contingency restriction was removed after OncoSec's Annual Stockholders Meeting held on January 12, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vested on January 12, 2018, and the remaining 75% are vesting in 36 equal monthly increments, which began on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":814583,"derivative":{"exercise_price":1.32,"exercise_date":"2018-01-12","expiration_date":"2027-11-04","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001493152-18-000657","document":"form4-dhillon.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315218000657/form4-dhillon.xml","form_type":"4"}},{"id":4245590,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-08-02T17:14:17.000Z","date":"2017-07-31","kind":"purchase","acquired":true,"shares":3000,"price":0.88,"value":2640.0,"ownership":{"direct":false,"nature":"By the Dhillon Living Trust dated May 24, 2016"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares purchased were pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Dhillon Living Trust dated May 24, 2016"}],"balance_after":227702,"source":{"system":"sec-edgar","filing":"0001493152-17-008406","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217008406/form4.xml","form_type":"4"}},{"id":4366814,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option to Purchase Common Stock","published_at":"2017-03-31T21:37:59.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":150000,"price":1.34,"value":201000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% vested on the Grant Date, and the remaining 75% to vest in 36 equal monthly increments, beginning on the first monthly anniversary of the Grant Date, pursuant to the OncoSec Medical Incorporated 2011 Stock Incentive Plan."}],"balance_after":564583,"derivative":{"exercise_price":1.34,"exercise_date":"2017-03-29","expiration_date":"2027-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-17-003329","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217003329/form4.xml","form_type":"4"}},{"id":4366813,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2017-03-31T21:37:59.000Z","date":"2017-03-29","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the restricted stock units are scheduled to vest on March 29, 2020, assuming continued employment and/or service through the applicable vesting date."}],"balance_after":275000,"derivative":{"exercise_date":"2020-03-29","expiration_date":"2020-03-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-17-003329","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217003329/form4.xml","form_type":"4"}},{"id":4471071,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-02-02T20:43:00.000Z","date":"2017-01-31","kind":"purchase","acquired":true,"shares":3000,"price":0.99,"value":2970.0,"ownership":{"direct":false,"nature":"By the Dhillon Living Trust dated May 24, 2016"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares purchased were pursuant to the OncoSec Medical Incorporated 2015 Employee Stock Purchase Plan"},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person is the trustee of the Dhillon Living Trust dated May 24, 2016"}],"balance_after":224702,"source":{"system":"sec-edgar","filing":"0001493152-17-001056","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315217001056/form4.xml","form_type":"4"}},{"id":4518870,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-16T17:25:16.000Z","date":"2016-12-14","kind":"grant","acquired":true,"shares":314583,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 25000 shares (previously granted on April 25, 2012), 12500 shares (previously granted on February 8, 2013), 100000 shares (previously granted on March 7, 2014), 25000 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 314583 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The stock options granted on December 14, 2016 will vest on the following schedule: 25% vested on the grant date; 1/36th of the remaining 75% will vest on each of the 36 subsequent monthly anniversaries of the grant date."}],"balance_after":314583,"derivative":{"exercise_price":1.29,"expiration_date":"2026-12-14","underlying":"Common Stock","underlying_shares":314583},"source":{"system":"sec-edgar","filing":"0001493152-16-015977","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015977/form4.xml","form_type":"4"}},{"id":4518869,"issuer":{"id":117092,"kind":"organization","name":"ONCOSEC MEDICAL Inc","symbol":"ONCS"},"owners":[{"id":25413,"kind":"person","name":"DHILLON PUNIT","position":1,"cik":"0001425052","reported_name":"DHILLON PUNIT","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-12-16T17:25:16.000Z","date":"2016-12-14","kind":"disposition_to_issuer","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These stock options were granted as Incentive Stock Options only to the extent that the $100,000 dollar limitation of 26 U.S.C. ss.422(d) is not exceeded; anything beyond that is deemed a Non-qualified Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 14, 2016, OncoSec Medical Incorporated cancelled, pursuant to its Stock Option Exchange Program, options previously granted to and held by the reporting person to purchase 25000 shares (previously granted on April 25, 2012), 12500 shares (previously granted on February 8, 2013), 100000 shares (previously granted on March 7, 2014), 25000 shares (previously granted on March 3, 2015), and 500000 shares (previously granted on August 21, 2015) of common stock. In exchange, and subject to the terms of the Stock Option Exchange Program, the reporting person received a replacement option for 314583 shares of common stock with an exercise price of $1.29 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock options were scheduled to fully vest on August 21, 2018, the third anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":5.76,"expiration_date":"2025-08-21","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001493152-16-015977","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1444307/000149315216015977/form4.xml","form_type":"4"}}],"next_cursor":"2016-12-16T17:25:16.000000Z,4518869"}